Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 41 to 48 of 48

Publication Record

Connections

Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.
Rodenhuis S, Boerrigter L, Top B, Slebos RJ, Mooi WJ, van't Veer L, van Zandwijk N
(1997) J Clin Oncol 15: 285-91
MeSH Terms: Adenocarcinoma, Adult, Aged, Carboplatin, Carcinoma, Non-Small-Cell Lung, Etoposide, Female, Gene Expression Regulation, Neoplastic, Genes, ras, Humans, Ifosfamide, Lung Neoplasms, Male, Middle Aged, Mutation, Prospective Studies, Survival Analysis
Added March 5, 2014
0 Communities
1 Members
0 Resources
17 MeSH Terms
Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.
Johnson DH, Paul DM, Hande KR, Shyr Y, Blanke C, Murphy B, Lewis M, De Vore RF
(1996) J Clin Oncol 14: 2054-60
MeSH Terms: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Carcinoma, Non-Small-Cell Lung, Female, Humans, Lung Neoplasms, Male, Middle Aged, Paclitaxel, Survival Rate
Added March 5, 2014
0 Communities
1 Members
0 Resources
12 MeSH Terms
Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma.
Stiff PJ, McKenzie RS, Alberts DS, Sosman JA, Dolan JR, Rad N, McCloskey T
(1994) J Clin Oncol 12: 176-83
MeSH Terms: Adult, Antineoplastic Combined Chemotherapy Protocols, Bone Marrow Diseases, Bone Marrow Transplantation, Carboplatin, Cyclophosphamide, Female, Humans, Male, Middle Aged, Mitoxantrone, Neoplasms, Ovarian Neoplasms, Treatment Outcome
Added March 5, 2014
0 Communities
1 Members
0 Resources
14 MeSH Terms
A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcome.
Stiff P, Bayer R, Camarda M, Tan S, Dolan J, Potkul R, Loutfi S, Kinch L, Sosman J, Peace D
(1995) Gynecol Oncol 57: 278-85
MeSH Terms: Adult, Antineoplastic Combined Chemotherapy Protocols, Bone Marrow Transplantation, Carboplatin, Cyclophosphamide, Dose-Response Relationship, Drug, Drug Administration Schedule, Epithelium, Female, Humans, Middle Aged, Mitoxantrone, Neoplasm Recurrence, Local, Ovarian Neoplasms, Prognosis, Risk Factors, Salvage Therapy, Treatment Outcome
Added March 5, 2014
0 Communities
1 Members
0 Resources
18 MeSH Terms
Paclitaxel plus carboplatin for advanced lung cancer: preliminary results of a Vanderbilt University phase II trial--LUN-46.
Johnson DH, Paul DM, Hande KR, DeVore RF
(1995) Semin Oncol 22: 30-3
MeSH Terms: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Bone Marrow, Carboplatin, Carcinoma, Non-Small-Cell Lung, Cohort Studies, Disease Progression, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Staging, Paclitaxel, Remission Induction, Survival Rate, Tennessee, Thrombocytopenia
Added March 5, 2014
0 Communities
1 Members
0 Resources
19 MeSH Terms
Salvage carboplatin therapy for advanced ovarian cancer after first-line treatment with cisplatin.
Williams LL, Fudge M, Burnett LS, Jones HW
(1992) Am J Clin Oncol 15: 331-6
MeSH Terms: Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Chemotherapy, Adjuvant, Cisplatin, Cystadenocarcinoma, Female, Humans, Middle Aged, Ovarian Neoplasms, Recurrence, Remission Induction, Salvage Therapy, Survival Analysis
Added March 5, 2014
0 Communities
1 Members
0 Resources
13 MeSH Terms
Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial.
Johnson DH, DeVore R, Greco FA, Walls J, Thomas M, Hande KR, Hainsworth JD
(1992) Semin Oncol 19: 50-6
MeSH Terms: Administration, Oral, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Carcinoma, Non-Small-Cell Lung, Etoposide, Female, Humans, Leukopenia, Lung Neoplasms, Male, Middle Aged, Neutropenia, Pilot Projects, Remission Induction, Survival Rate, Thrombocytopenia
Added March 5, 2014
0 Communities
1 Members
0 Resources
18 MeSH Terms
Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trial.
Johnson DH, Hainsworth JD, DeVore R, Hande KR, Greco FA
(1992) Oncology 49 Suppl 1: 57-61; discussion 61-2
MeSH Terms: Administration, Oral, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Carcinoma, Non-Small-Cell Lung, Etoposide, Female, Humans, Leukocyte Count, Lung Neoplasms, Male, Middle Aged, Neoplasm Staging, Platelet Count
Added March 5, 2014
0 Communities
1 Members
0 Resources
13 MeSH Terms